GLP-1 receptor agonists, like Ozempic and Wegovy, have been everywhere over the past few years, and research seems to be ...

Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...

Ozempic and other GLP-1 agonist medications have risen in popularity over the last few years due to their touted blood sugar management and weight-loss effects. However, some supp ...

Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...

W ith more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...

News of Biden administration's proposal to require Medicare and Medicaid health insurance to cover weight loss drugs could trigger private employers to do the same.

"More work is now needed to implement the results of this study into clinical practice and improve access to GLP-1 receptor agonists to people who will benefit from them," he added.

Weight-loss drugs like Ozempic and Wegovy are gaining popularity as quick fixes for shedding pounds. Known as GLP-1 agonists, ...

GLP-1 drugs such as Ozempic and Mounjaro have been heralded as some of the most important drug breakthroughs ever . This has led to huge demand for ...

A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, ...